The FDA has updated its guidance documents on general wellness products and clinical decision support software to ease the path to market for AI-enabled products posing a low risk to patients. (Shutterstock)
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
